Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 1983 Oct;73(10):1161–1164. doi: 10.2105/ajph.73.10.1161

The association of marijuana use with outcome of pregnancy.

S Linn, S C Schoenbaum, R R Monson, R Rosner, P C Stubblefield, K J Ryan
PMCID: PMC1651077  PMID: 6604464

Abstract

We analyzed interview and medical record data of 12,424 women to evaluate the relationship between marijuana usage and adverse outcomes of pregnancy. Low birthweight, short gestation, and major malformations occurred more often among offspring of marijuana users. When we used logistic regression to control for demographic characteristics, habits, and medical history data, these relationships were not statistically significant. The odds ratio for the occurrence of major malformations among marijuana users was 1.36, higher than odds ratios for other exogenous variables, and the 95 per cent confidence interval was 0.97-1.91. More data are needed to establish firmly or rule out an association between marijuana usage and major malformations. Until more information is available, women should be advised not to use marijuana during pregnancy.

Full text

PDF
1161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel E. L. Prenatal exposure to cannabis: a critical review of effects on growth, development, and behavior. Behav Neural Biol. 1980 Jun;29(2):137–156. doi: 10.1016/s0163-1047(80)90469-0. [DOI] [PubMed] [Google Scholar]
  2. Bloch E., Thysen B., Morrill G. A., Gardner E., Fujimoto G. Effects of cannabinoids on reproduction and development. Vitam Horm. 1978;36:203–258. doi: 10.1016/s0083-6729(08)60985-1. [DOI] [PubMed] [Google Scholar]
  3. Bogdanoff B., Rorke L. B., Yanoff M., Warren W. S. Brain and eye abnormalities. Possible sequelae to prenatal use of multiple drugs including LSD. Am J Dis Child. 1972 Feb;123(2):145–148. [PubMed] [Google Scholar]
  4. Carakushansky G., Neu R. L., Gardner L. I. Lysergide and cannabis as possible teratogens in man. Lancet. 1969 Jan 18;1(7586):150–151. doi: 10.1016/s0140-6736(69)91156-8. [DOI] [PubMed] [Google Scholar]
  5. Fried P. A. Marihuana use by pregnant women: neurobehavioral effects in neonates. Drug Alcohol Depend. 1980 Dec;6(6):415–424. doi: 10.1016/0376-8716(80)90023-x. [DOI] [PubMed] [Google Scholar]
  6. Hecht F., Beals R. K., Lees M. H., Jolly H., Roberts P. Lysergic-acid-diethylamide and cannabis as possible teratogens in man. Lancet. 1968 Nov 16;2(7577):1087–1087. doi: 10.1016/s0140-6736(68)91569-9. [DOI] [PubMed] [Google Scholar]
  7. Hingson R., Alpert J. J., Day N., Dooling E., Kayne H., Morelock S., Oppenheimer E., Zuckerman B. Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics. 1982 Oct;70(4):539–546. [PubMed] [Google Scholar]
  8. Linn S., Schoenbaum S. C., Monson R. R., Rosner B., Stubblefield P. G., Ryan K. J. No association between coffee consumption and adverse outcomes of pregnancy. N Engl J Med. 1982 Jan 21;306(3):141–145. doi: 10.1056/NEJM198201213060304. [DOI] [PubMed] [Google Scholar]
  9. Vardaris R. M., Weisz D. J., Fazel A., Rawitch A. B. Chronic administration of delta-9-tetrahydrocannabinol to pregnant rats: studies of pup behavior and placental transfer. Pharmacol Biochem Behav. 1976 Mar;4(3):249–254. doi: 10.1016/0091-3057(76)90236-7. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES